TFA
USNA icon

Transamerica Financial Advisors’s Usana Health Sciences USNA Stock Holding History

Transamerica Financial Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64 Hold
3
– – ﹤0.01% 2096
2026
Q1 		$52 Buy
+3
New +$60 ﹤0.01% 1881

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Transamerica Financial Advisors's USNA Position: Q2 2026 in Review

Transamerica Financial Advisors held its Usana Health Sciences (USNA) position steady in Q2 2026 at 3 shares worth $64. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Transamerica Financial Advisors first reported a position in USNA in Q1 2026 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Transamerica Financial Advisors held 3 shares of Usana Health Sciences worth $64 as of Q2 2026.
  • Transamerica Financial Advisors left its Usana Health Sciences share count unchanged in Q2 2026.
  • Usana Health Sciences made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #2096 holding.
  • Transamerica Financial Advisors first reported a position in Usana Health Sciences in Q1 2026 and has held it in 2 quarters since.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.